You are here:
Drugmakers
#

Drugmakers

Get Alerts

Articles

View all

Uh oh.. is Ranbaxy in more trouble?

Jan 13, 2014

Uh oh.. is Ranbaxy in more trouble?

The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to nearly a one-month low. #United States #Ranbaxy #Daiichi Sankyo #US FDA #drugmaker #Toansa
Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

Nov 28, 2013

Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Aug 12, 2013

US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. #United States #NewsTracker #US FDA #drugmaker #Indian drugmakers
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Jun 05, 2013

Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Ranbaxy may be facing a potential ban on its generic drugs in United States but however Ranbaxy is not the only company that has faced such a crisis. #WhyNow #Ranbaxy Laboratories #US FDA #generic drugmakers
Ranbaxy's $500 mn settlement: All you need to know

May 14, 2013

Ranbaxy's $500 mn settlement: All you need to know

Ranbaxy will pay $500 mn to resolve fraud allegations that the company sold adulterated drugs and lied about it to US regulators. #US #CompanyWatch #Ranbaxy #Pharma #generic drugmakers

Wire

View all

Ranbaxy's $500 mn settlement: All you need to know

Jul 17, 2014

Drugmaker Novartis to eke out more cost savings to lift margins

Swiss drugmaker Novartis posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins as it prepares a radical business overhaul... #Switzerland #Novartis
Ranbaxy's $500 mn settlement: All you need to know

Jul 18, 2014

U.S. drugmaker AbbVie finally wins Dublin's Shire with $55 billion deal

AbbVie bought Dublin-based Shire in a $54.7 billion deal that will allow it to slash its tax bill by relocating to Britain... #Switzerland #Novartis
Ranbaxy's $500 mn settlement: All you need to know

Jul 24, 2014

Gilead reports $5.8 billion in sales of hepatitis C drug

Amid concerns over the high cost of its new treatment for hepatitis C, drugmaker Gilead Sciences Inc. reported $5.8 billion in sales for its blockbuster Sovaldi drug in the first half of 2014... #Switzerland #Novartis
LIVE